Provided by Tiger Trade Technology Pte. Ltd.

Charles River Laboratories

300.30
-4.6600-1.53%
Post-market: 305.945.64+1.88%19:56 EDT
Volume:1.24M
Turnover:373.27M
Market Cap:14.34B
PE:-61.52
High:305.18
Open:303.38
Low:294.28
Close:304.96
52wk High:333.30
52wk Low:146.20
Shares:47.74M
Float Shares:47.20M
Volume Ratio:1.17
T/O Rate:2.63%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.8814
EPS(LYR):-2.9122
ROE:-7.52%
ROA:4.11%
PB:5.05
PE(LYR):-103.12

Loading ...

Charles River Laboratories International, - 2030 Target for Organic Revenue Growth is 5%-7% Cagr 2027-2030

THOMSON REUTERS
·
Sep 24

Charles River Laboratories International, - Expects over $300 Mln Cumulative Savings from 2027 Through 2030

THOMSON REUTERS
·
Sep 24

Charles River Laboratories International, Inc.: Reaffirms 2026 Financial Guidance with Revenue and Non-Gaap Earnings Per Share Expected at Upper Ends of Prior Ranges

THOMSON REUTERS
·
Sep 24

Charles River Laboratories International Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Sep 23

Charles River Labs (CRL) Receives a New Rating from Stephens

TIPRANKS
·
Sep 22

Analysts Offer Insights on Healthcare Companies: Charles River Labs (CRL) and AgomAb Therapeutics NV ADR (AGMB)

TIPRANKS
·
Sep 21

Charles River Laboratories International Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Sep 18

Analysts Offer Insights on Healthcare Companies: Charles River Labs (CRL) and Amgen (AMGN)

TIPRANKS
·
Sep 17

Charles River price target raised to $330 from $250 at Argus

TIPRANKS
·
Sep 17

Argus Research Adjusts Charles River Laboratories International PT to $330 From $250, Maintains Buy Rating

MT Newswires Live
·
Sep 17

Charles River introduces rapid cell banking programs to reduce timelines

TIPRANKS
·
Sep 17

Charles River Launches Rapid Cell Banking Platform, Cuts Production Timeline 40% vs Industry Standard

Reuters
·
Sep 17

Charles River Laboratories International, Inc. : Argus Research Raises Target Price to $330 from $250

THOMSON REUTERS
·
Sep 17

U.S. Research Roundup-Celcuity, Fluence Energy, Salesforce

Reuters
·
Sep 17

NYSE Order Imbalance 74862.0 Shares on Buy Side

THOMSON REUTERS
·
Sep 17

Charles River Laboratories to Provide Update on New Approach Methodologies Strategy on Investor Day, RBC Says

MT Newswires Live
·
Sep 16

Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX), Ascendis Pharma (ASND) and Charles River Labs (CRL)

TIPRANKS
·
Sep 16

Charles River Laboratories International Inc. Stock Underperforms Monday When Compared to Competitors

Dow Jones
·
Sep 15

Charles River Laboratories International Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Sep 12

Charles River Labs to Present at Morgan Stanley Global Healthcare Conference

Reuters
·
Sep 11